• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home 2 Minute Medicine

Juror perception of radiologist liability can be affected by artificial intelligence (AI) use in diagnosis

byCheng En XiandDeepti Shroff
October 8, 2025
in 2 Minute Medicine
Reading Time: 3 mins read
Significant number of wrong-patient errors in radiology reports
Share on FacebookShare on Twitter

1. Bernstein and colleagues evaluated potential jurors’ perception of culpability of a radiologist in a hypothetical false-negative diagnosis malpractice case.

2. An increased perception of liability was found if the AI found a positive result. Liability perception was lower if data regarding AI precision was presented.

Evidence Rating Level: 1 (Excellent)

Study Rundown: AI advancements can lead to early disease protection and improved diagnostic accuracy. However, radiologists may be more vulnerable to malpractice allegations when they disagree with AI in a false-negative case. Bernstein and colleagues recruited participants eligible for jury duty in the US to evaluate the culpability of a radiologist in two malpractice clinical scenarios. Each participant was randomly assigned to one of five conditions representing various levels of AI use and disclosure related to the case. The study found that participants were equally likely to side with the radiologist if no AI was used in the scenario compared to if AI agreed with a false negative. The participants were more likely to side with the plaintiff if the AI disagreed with the radiologist’s false negative diagnosis. Additionally, the participants were less likely to side with the plaintiff if the scenario included the AI’s false omission rate (FOR) and false discovery rate (FDR). This study empirically demonstrated how potential jurors react to a potential malpractice case and how to mitigate radiologist penalization by presenting data on AI precision.

Click here to read the study in NEJM AI

Relevant Reading: AI in radiology: Legal responsibilities and the car paradox

RELATED REPORTS

FDA-cleared AI devices rarely have patient outcome data

Celebrity body scans are colliding with radiology evidence

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

In-Depth [randomized controlled trial]: 1,334 participants who met the following criteria were recruited: adults 18-89 years of age living in the US and who had English as a primary language. Participants were randomized to two clinical scenarios that involved a radiologist who failed to identify an abnormality and was sued by the patient or their family (plaintiffs). The participants indicated whether the radiologist had met their duty of care by answering a single yes/no question: “Did the radiologist meet their duty of care to the patient?” A response of “no” meant siding with the plaintiff, finding the radiologist liable; “yes” meant siding with the defendant (the radiologist). Within the two scenarios – one related to a brain bleed and the other related to lung cancer, participants were further randomized to five experimental conditions: no AI (control), AI finds pathology (AI disagree), AI found no pathology (AI agree), AI disagree and the AI has an FDR of 50% (AI disagree + FDR), and AI agree and the AI has an FOR of 1% (AI agree + FOR). In both scenarios, there was no significant difference in the proportion of “no” between the no AI and AI agree conditions (brain bleed: 50.0% vs 56.3%, p = 0.33; lung cancer: 63.5% vs 65.2%, p = 0.77). Participants sided with the plaintiffs more often in the AI disagreed condition versus the AI agreed condition (brain bleed: 72.9% vs 50.0%, p = 0.001; lung cancer: 78.7% vs 65.2%, p = 0.04). Meanwhile, when the participants were given the AI’s FOR, only 34.0% and 56.4% of the participants sided with the plaintiffs in the brain bleed and lung cancer scenarios, respectively. The study was limited by its ecological validity, as participants received fewer details than real jurors for a real case. Overall, this study provided empirical evidence on how potential jurors react to a malpractice case involving AI and how the presentation of AI data affects legal outcomes.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: artifical intelligencemachine learningmalpracticeradiology
Previous Post

An online program combining mindfulness strategies with exercise may be effective for patients with chronic pain

Next Post

Traumatic brain injury may be associated with increased risk of amyotrophic lateral sclerosis

RelatedReports

Public Health

FDA-cleared AI devices rarely have patient outcome data

September 10, 2026
MRI helps predict risk of local recurrence in upper rectal cancers
Imaging and Intervention

Celebrity body scans are colliding with radiology evidence

September 4, 2026
Combination salmeterol-fluticasone therapy noninferior to fluticasone monotherapy for asthma events: The VESTRI trial
Artificial Intelligence

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

May 12, 2026
No obesity paradox found between BMI, stroke, and death
Artificial Intelligence

Large language models (LLMs) performed poorly in navigating early clinical diagnostic uncertainty

April 20, 2026
Next Post
Quick Take: Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography

Traumatic brain injury may be associated with increased risk of amyotrophic lateral sclerosis

Age not associated with differences in radiosurgical arteriovenous malformation outcomes

Surgical and conservative management strategies for acute subdural hematoma are associated with similar functional outcomes

Mild-to-moderate hypertriglyceridemia associated with higher risk of acute pancreatitis

Smoking and prior acute pancreatitis attacks are risk factors for poor glycemic control in patients with post-chronic pancreatitis diabetes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.